Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,823,740 papers from all fields of science
Search
Sign In
Create Free Account
17-allylaminogeldanamycin
Known as:
17-allylamino-geldanamycin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
tanespimycin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Phase I trial of intravenous 17-allylaminogeldanamycin (A) and oral sorafenib (B) in pretreated advanced malignancy: Plasma Hsp90α induction correlates with clinical benefit
U. Vaishampayan
,
E. Sausville
,
+6 authors
P. LoRusso
2007
Corpus ID: 74348035
3531 Background: The combination of B with A was evaluated to recommend a phase II dose for using A in combination with B, since…
Expand
2007
2007
Study of 17-Allylaminogeldanamycin in Relapsed / Refractory Pediatric Patients with SolidTumors : AChildren ’ s Oncology Group Study
B. Weigel
,
S. Blaney
,
+11 authors
P. Adamson
2007
Corpus ID: 28297626
Purpose:To determine the recommended phase 2 dose, dose-limiting toxicities (DLT), pharmacokinetic profile, and pharmacodynamics…
Expand
2003
2003
Gpcrs: A solid view of GPCRs
S. Farley
Nature reviews. Drug discovery
2003
Corpus ID: 37249066
Inhibitors of heat-shock protein 90 (Hsp90) — which regulates the function and stability of key signalling proteins — have been…
Expand
2003
2003
In Brief
In Brief
Nature reviews. Drug discovery
2003
Corpus ID: 38024505
Inhibitors of heat-shock protein 90 (Hsp90) — which regulates the function and stability of key signalling proteins — have been…
Expand